Literature DB >> 18486090

The role of vulvar skin biopsy in the evaluation of chronic vulvar pain.

Anneli R Bowen1, Amber Vester, Lily Marsden, Scott R Florell, Howard Sharp, Paul Summers.   

Abstract

Sixty-one percent of refractory vulvodynia patients evaluated in a tertiary care vulvovaginal clinic had clinically relevant dermatoses based on dermatopathologist-analyzed vulvar biopsy including: lichen sclerosus, allergic/irritant dermatitis, lichen planus, and other inflammatory or neoplastic dermatoses. Given the frequency of dermatologic disease, vulvar biopsy and analysis by a dermatopathologist are recommended in patients with vulvodynia.

Entities:  

Mesh:

Year:  2008        PMID: 18486090     DOI: 10.1016/j.ajog.2008.03.004

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  5 in total

1.  Unifying clinical care between specialties: a model for genital disease.

Authors:  Anna Ascott; Suchitra Chinthapalli; Karen Gibbon
Journal:  J R Soc Med       Date:  2017-02-09       Impact factor: 5.344

2.  Desquamative Inflammatory Vaginitis and Plasma Cell Vulvitis Represent a Spectrum of Hemorrhagic Vestibulovaginitis.

Authors:  Myriarm Song; Tania Day; Len Kliman; Geoff Otton; Desiree Yap; Ross Pagano; Yasmin Tan; James Scurry
Journal:  J Low Genit Tract Dis       Date:  2022-01-01       Impact factor: 1.925

3.  Influence of Photodynamic Therapy on Lichen Sclerosus with Neoplastic Background.

Authors:  Magdalena Bizoń; Danuta Maślińska; Włodzimierz Sawicki
Journal:  J Clin Med       Date:  2022-02-19       Impact factor: 4.241

4.  Diagnostic criteria for erosive lichen planus affecting the vulva: an international electronic-Delphi consensus exercise.

Authors:  R C Simpson; K S Thomas; P Leighton; R Murphy
Journal:  Br J Dermatol       Date:  2013-08       Impact factor: 9.302

5.  Skin and mucous membranes' manifestations of dermatological diseases within the genital area in females.

Authors:  Katarzyna Plagens-Rotman; Renata Przybylska; Zygmunt Adamski; Magdalena Czarnecka-Operacz
Journal:  Postepy Dermatol Alergol       Date:  2018-04-24       Impact factor: 1.837

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.